Search results
Results from the WOW.Com Content Network
William Sawalich (born October 3, 2006) is an American professional stock car racing driver. He competes full-time in the NASCAR Xfinity Series , driving the No. 18 Toyota GR Supra for Joe Gibbs Racing .
William Sawalich, driving for Joe Gibbs Racing, would hold off a fierce battle with Connor Zilisch, and earned his eleventh career ARCA Menards Series win, his sixth career ARCA Menards Series East win, and his seventh of the season. Sawalich would also dominate the entire race, leading a race-high 149 laps.
Rifampicin is the INN and BAN, while rifampin is the USAN. Rifampicin may be abbreviated R, RMP, RA, RF, or RIF (US). [citation needed] Rifampicin is also known as rifaldazine, [63] [64] rofact, and rifampin in the United States, also as rifamycin SV. [65]
William Sawalich: Grant Enfinger: Grant Enfinger: Chevrolet: 9 CR7 Motorsports: Report: 21 Baptist Health 200: Corey Heim: Corey Heim: Grant Enfinger: Chevrolet: 9 CR7 Motorsports: Report: 22 Zip Buy Now, Pay Later 200: Christian Eckes: Christian Eckes: Christian Eckes: Chevrolet: 19 McAnally-Hilgemann Racing: Report: Championship 4 23 NASCAR ...
What links here; Upload file; Special pages; Printable version; Page information; Get shortened URL
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
Scientists at the Italian drug company Achifar discovered rifabutin in 1975. (Eventually Archifar became part of Farmitalia Carlo Erba, a unit of the conglomerate Montedison which was subsequently bought by Pharmacia) This company's Adria Laboratories subsidiary filed for Food and Drug Administration (FDA) approval of rifabutin under the brand name Mycobutin in the early 1990s and the drug ...
Rifapentine in pregnant women has not been studied, but animal reproduction studies have resulted in fetal harm and were teratogenic. If rifapentine or rifampin are used in late pregnancy, coagulation should be monitored due to a possible increased risk of maternal postpartum hemorrhage and infant bleeding. [2]